Rocio
Ferreiro Iglesias
Wageningen UR
Wageningen, HolandaPublicaciones en colaboración con investigadores/as de Wageningen UR (1)
2022
-
The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study
Journal of Crohn's & colitis, Vol. 16, Núm. 11, pp. 1676-1686